scout
Opinion|Videos|August 14, 2024

Monitoring Response in Immune Checkpoint Inhibitor-Based RCC Therapy

Medical experts examine strategies for monitoring treatment response in patients initiating first-line immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME